Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade

Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade

Systemic treatment options for patients with locally advanced or metastatic basal cell carcinoma (BCC) are limited, particularly when tumors are refractory to anti-programmed cell death protein-1 (PD-1). A better understanding of immune checkpoint expression within the BCC tumor microenvironment may...

Full description

Bibliographic Details
Main Authors: Abha Soni, Evan J Lipson, Peter Nguyen, Haiying Xu, Daphne Wang, Janis M Taube, Megan D Schollenberger, Jonathan Lai, Julie Stein Deutsch, Kara M Schenk, Elizabeth M Will, Logan L Engle, Alexandra Ogurtsova, Vrinda Madan, Jennifer K Chong, Benjamin F Green
Format: Article
Language:English
Published: BMJ Publishing Group 2023-12-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/12/e007463.full

Internet

https://jitc.bmj.com/content/11/12/e007463.full

Similar Items